90 related articles for article (PubMed ID: 11697650)
81. A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Honma Y
Leuk Lymphoma; 2001; 42(5):953-62. PubMed ID: 11697650
[TBL] [Abstract][Full Text] [Related]
82. Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia.
Honma Y; Niitsu N
Leuk Lymphoma; 2000 Sep; 39(1-2):57-66. PubMed ID: 10975384
[TBL] [Abstract][Full Text] [Related]
83. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Niitsu N; Honma Y
Leuk Lymphoma; 1999 Jul; 34(3-4):261-71. PubMed ID: 10439363
[TBL] [Abstract][Full Text] [Related]
84. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
Johnston JB
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
[TBL] [Abstract][Full Text] [Related]
85. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
86. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
87.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
88.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
89.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
90.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]